Place du pathologiste dans la prise en charge des cancers en situation néoadjuvante = The pathologist's role in neoadjuvant treatment of cancerAZRIA, David; BIBEAU, Frédéric.Annales de pathologie (Print). 2011, Vol 31, Num 6, issn 0242-6498, 69 p.Serial Issue

Neoadjuvant endocrine therapy as a drug development strategyELLIS, Matthew J.Clinical cancer research. 2004, Vol 10, Num 1, pp 391s-395s, issn 1078-0432, 2Conference Paper

Developing Safety Criteria for Introducing New Agents into Neoadjuvant TrialsDEMICHELE, Angela; BERRY, Donald A; BENZ, Chris et al.Clinical cancer research (Print). 2013, Vol 19, Num 11, pp 2817-2823, issn 1078-0432, 7 p.Article

Accelerated Approval for Pertuzumab in the Neoadjuvant Setting: Winds of Change?ESSERMAN, Laura J; DEMICHELE, Angela.Clinical cancer research (Print). 2014, Vol 20, Num 14, pp 3632-3636, issn 1078-0432, 5 p.Article

Infiltrats immunologiques et chimiothérapie néoadjuvante = Immune infiltrates and neoadjuvant chemotherapyGHIRINGHELLI, F; ARNOULD, L; COUDERT, B et al.La Lettre du sénologue. 2010, Num 47, pp 34-35, issn 1289-2505, 2 p.Conference Paper

Adjuvant and neoadjuvant therapy for primary GISTEISENBERG, Burton L; SMITH, Kerrington D.Cancer chemotherapy and pharmacology. 2011, Vol 67, issn 0344-5704, S3-S8, SUP1Article

Neoadjuvant proton beam radiotherapy combined with subsequent endoresection of choroidal melanomasBECHRAKIS, Nikolaos E; FOERSTER, Michael H.International ophthalmology clinics. 2006, Vol 46, Num 1, pp 95-107, issn 0020-8167, 13 p.Article

Molecular Oncology and the Neoadjuvant Setting: the Perfect Blend for Treatment Personalization and Clinical Trial DesignGENERALI, Daniele; BERRUTI, Alfredo; BOTTINI, Alberto et al.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 67-70, issn 1052-6773, 4 p.Conference Paper

Neoadjuvant Chemotherapy: Early Response as a Guide for Further Treatment: Clinical, Radiological, and BiologicalUNTCH, Michael; VON MINCKWITZ, Gunter.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 138-141, issn 1052-6773, 4 p.Conference Paper

Les traitements néoadjuvants TNA (RPC 2013)SALMON, R; CEUGNART, L; SELZ, J et al.Oncologie (Paris). 2013, Vol 15, Num 12, pp 607-634, issn 1292-3818, 28 p.Conference Paper

Is there still a role for neoadjuvant chemotherapy in head and neck cancer?LICITRA, L; VERMORKEN, J. B.Annals of oncology. 2004, Vol 15, Num 1, pp 7-11, issn 0923-7534, 5 p.Article

Influence of Neoadjuvant Chemotherapy on Outcomes of Immediate Breast ReconstructionAZZAWI, Khayam; ISMAIL, Amir; EARL, Helena et al.Plastic and reconstructive surgery (1963). 2010, Vol 126, Num 1, pp 1-11, issn 0032-1052, 11 p.Conference Paper

The y symbol : An important classification tool for neoadjuvant cancer treatmentBRIERLEY, James D; GREENE, Frederick L; SOBIN, Leslie H et al.Cancer. 2006, Vol 106, Num 11, pp 2526-2527, issn 0008-543X, 2 p.Article

Adjuvant and neoadjuvant therapyHARRIS, David T.Seminars in oncology. 1995, Vol 22, Num 6, pp 529-680, issn 0093-7754Serial Issue

Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapyTAKATA, Ryo; KATAGIRI, Toyomasa; KANEHIRA, Mitsugu et al.Cancer science. 2007, Vol 98, Num 1, pp 113-117, issn 1347-9032, 5 p.Article

Pathological grading of regression following neoadjuvant chemoradiation therapy: the clinical need is nowMACGREGOR, Tom P; MAUGHAN, Tim S; SHARMA, Ricky A et al.Journal of clinical pathology. 2012, Vol 65, Num 10, pp 867-871, issn 0021-9746, 5 p.Article

Neoadjuvant Chemotherapy and Targeted Therapies: a Promising StrategyMETZGER-FILHO, Otto; DE AZAMBUJA, Evandro.Journal of the National Cancer Institute. Monographs. 2011, Vol 43, pp 116-119, issn 1052-6773, 4 p.Conference Paper

Sleeve resections with unprotected bronchial anastomoses are safe even after neoadjuvant therapySTORELLI, Erica; TUTIC, Michaela; KESTENHOLZ, Peter et al.European journal of cardio-thoracic surgery. 2012, Vol 42, Num 1, pp 77-81, issn 1010-7940, 5 p.Article

Stage-for-stage comparison of definitive chemoradiotherapy, surgery alone and neoadjuvant chemotherapy for oesophageal carcinomaMORGAN, M. A; LEWIS, W. G; CASBARD, A et al.British journal of surgery. 2009, Vol 96, Num 11, pp 1300-1307, issn 0007-1323, 8 p.Article

36_th ASCO Annual Meeting, May 20-23, 2000 - New Orleans, Louisiana. Compte rendu du Congrès de la Société Américaine d'Oncologie CliniqueCHAOUCHE, Malika.Cancérologie aujourd'hui (Paris). 2000, Vol 9, Num 5, issn 1140-9916, 40 p.Conference Proceedings

Prognostic value of axillary lymph node status after neoadjuvant chemotherapy. Results from a multicentre studySAXENA, Nakul; HARTMAN, Mikael; CHENG HAR YIP et al.European journal of cancer (1990). 2011, Vol 47, Num 8, pp 1186-1192, issn 0959-8049, 7 p.Article

Actualités dans le cancer du sein au SABCS - Certitudes, incertitudes et nouvelles pistes (San Antonio Breast Cancer Symposium, 9-12 décembre 2010)CHAPELLE-MARCILLAC, I.La Lettre du cancérologue (Boulogne). 2011, Vol 20, Num 3, issn 1165-113X, 15 p., SUP3Serial Issue

Who profits from neoadjuvant radiochemotherapy for locally advanced esophageal carcinoma?KERSTING, Stephan; KONOPKE, Ralf; DITTERT, Dag et al.Journal of gastroenterology and hepatology. 2009, Vol 24, Num 5, pp 886-895, issn 0815-9319, 10 p.Article

Gene expression profiles of multiple breast cancer phenotypes and response to neoadjuvant chemotherapyDRESSMAN, Holly K; HANS, Christopher; DEWHIRST, Mark W et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 819-826, issn 1078-0432, 8 p., 1Article

Evidence-based use of neoadjuvant taxane in operable and inoperable breast cancerESTEVEZ, Laura G; GRADISHAR, William J.Clinical cancer research. 2004, Vol 10, Num 10, pp 3249-3261, issn 1078-0432, 13 p.Article